Literature DB >> 19387465

A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation?

T Ripperger, D Steinemann, G Göhring, J Finke, C M Niemeyer, B Strahm, B Schlegelberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19387465     DOI： 10.1038/leu.2009.87

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  17 in total

1.  Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Lynn R Goldin; Sigurdur Y Kristinsson; Xueying Sharon Liang; Asa R Derolf; Ola Landgren; Magnus Björkholm
Journal:  J Clin Oncol       Date:  2011-12-12       Impact factor: 44.544

2.  Clinical utility gene card for: Familial platelet disorder with associated myeloid malignancies.

Authors:  Tim Ripperger; Kiran Tawana; Christian Kratz; Brigitte Schlegelberger; Jude Fitzgibbon; Doris Steinemann
Journal:  Eur J Hum Genet       Date:  2016-01-27       Impact factor: 4.246

3.  Managing individuals with propensity to myeloid malignancies due to germline RUNX1 deficiency.

Authors:  Tim Ripperger; Marcel Tauscher; Detlef Haase; Frank Griesinger; Brigitte Schlegelberger; Doris Steinemann
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

Review 4.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

5.  Monitoring and treatment of MDS in genetically susceptible persons.

Authors:  Stella M Davies
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 6.  Myeloid neoplasms with germline DDX41 mutation.

Authors:  Jesse J C Cheah; Christopher N Hahn; Devendra K Hiwase; Hamish S Scott; Anna L Brown
Journal:  Int J Hematol       Date:  2017-05-25       Impact factor: 2.490

Review 7.  A role for RUNX1 in hematopoiesis and myeloid leukemia.

Authors:  Motoshi Ichikawa; Akihide Yoshimi; Masahiro Nakagawa; Nahoko Nishimoto; Naoko Watanabe-Okochi; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2013-04-24       Impact factor: 2.490

8.  Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy.

Authors:  Chi Young Ok; Vasiliki Leventaki; Sa A Wang; Courtney Dinardo; L Jeffrey Medeiros; Sergej Konoplev
Journal:  Am J Clin Pathol       Date:  2016-01-22       Impact factor: 2.493

9.  C-terminal RUNX1 mutation in familial platelet disorder with predisposition to myeloid malignancies.

Authors:  Kateřina Staňo Kozubík; Lenka Radová; Michaela Pešová; Kamila Réblová; Jakub Trizuljak; Karla Plevová; Veronika Fiamoli; Jaromír Gumulec; Helena Urbánková; Tomáš Szotkowski; Jiří Mayer; Šárka Pospíšilová; Michael Doubek
Journal:  Int J Hematol       Date:  2018-08-06       Impact factor: 2.490

10.  RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.

Authors:  Anna L Brown; Peer Arts; Catherine L Carmichael; Milena Babic; Julia Dobbins; Chan-Eng Chong; Andreas W Schreiber; Jinghua Feng; Kerry Phillips; Paul P S Wang; Thuong Ha; Claire C Homan; Sarah L King-Smith; Lesley Rawlings; Cassandra Vakulin; Andrew Dubowsky; Jessica Burdett; Sarah Moore; Grace McKavanagh; Denae Henry; Amanda Wells; Belinda Mercorella; Mario Nicola; Jeffrey Suttle; Ella Wilkins; Xiao-Chun Li; Joelle Michaud; Peter Brautigan; Ping Cannon; Meryl Altree; Louise Jaensch; Miriam Fine; Carolyn Butcher; Richard J D'Andrea; Ian D Lewis; Devendra K Hiwase; Elli Papaemmanuil; Marshall S Horwitz; Georges Natsoulis; Hugh Y Rienhoff; Nigel Patton; Sally Mapp; Rachel Susman; Susan Morgan; Julian Cooney; Mark Currie; Uday Popat; Tilmann Bochtler; Shai Izraeli; Kenneth Bradstock; Lucy A Godley; Alwin Krämer; Stefan Fröhling; Andrew H Wei; Cecily Forsyth; Helen Mar Fan; Nicola K Poplawski; Christopher N Hahn; Hamish S Scott
Journal:  Blood Adv       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.